Hans Pharma Co., Ltd. is a South Korea-based biotechnology and cosmeceutical company specializing in regenerative science, advanced skincare, and functional bio-materials. Established in 2014 as a subsidiary of Hans Biomed, a globally recognized biomedical company, Hans Pharma focuses on developing innovative solutions based on stem cell-derived technologies, exosomes, secretome research, and skin regeneration science.

Driven by its philosophy of Healthy Aging, Hans Pharma combines advanced biotechnology with aesthetic innovation to provide high-performance cosmeceutical products for skin, scalp, and beauty care. The companys research and development activities are centered on regenerative materials, functional bioactive ingredients, and next-generation cosmetic technologies designed to support skin vitality, hydration, barrier recovery, and overall skin health.

Hans Pharma operates an R&D-focused business model and offers a diverse portfolio that includes professional skincare solutions, scalp care products, aesthetic cosmetics, and OEM/ODM manufacturing services. Leveraging the scientific expertise and tissue engineering technologies of the Hans Group, the company continuously develops differentiated formulations that meet the evolving demands of global aesthetic and beauty markets.

With a growing international presence, Hans Pharma exports its products to various global markets and actively collaborates with distributors, medical professionals, and aesthetic partners worldwide. Through continuous innovation, strict quality control, and scientific research, the company strives to become a trusted global leader in regenerative cosmeceuticals and biotechnology-based beauty solutions.